The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
Takes charge to lead business innovation, strategy, alliance & partnerships
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
The President said that there is a need to spread more and more awareness regarding the causes, diagnosis and treatment of cancer
Company receives acceptability, in principle, for ZyVac TCV making it eligible for purchase by United Nations procurement agencies
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
Subscribe To Our Newsletter & Stay Updated
